3s54
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | [[Image:3s54.jpg|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3s54", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3s54| PDB=3s54 | SCENE= }} | ||
- | + | ===HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P21212=== | |
- | + | ||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_22238126}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 22238126 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_22238126}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | [[3s54]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3S54 OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:022238126</ref><references group="xtra"/> | ||
+ | [[Category: HIV-1 retropepsin]] | ||
+ | [[Category: Human immunodeficiency virus 1]] | ||
+ | [[Category: Tie, Y F.]] | ||
+ | [[Category: Wang, Y F.]] | ||
+ | [[Category: Weber, I T.]] | ||
+ | [[Category: Aspartic protease]] | ||
+ | [[Category: Darunavir]] | ||
+ | [[Category: Drug resistance]] | ||
+ | [[Category: Hiv/aid]] | ||
+ | [[Category: Hydrolase-hydrolase inhibitor complex]] | ||
+ | [[Category: Molecular recognition]] |
Revision as of 07:37, 21 March 2012
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P21212
Template:ABSTRACT PUBMED 22238126
About this Structure
3s54 is a 2 chain structure with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
Reference
- Tie Y, Wang YF, Boross PI, Chiu TY, Ghosh AK, Tozser J, Louis JM, Harrison RW, Weber IT. Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors. Protein Sci. 2012 Mar;21(3):339-50. doi: 10.1002/pro.2019. Epub 2012 Jan 24. PMID:22238126 doi:10.1002/pro.2019